Heiyoun Jung - Concepedia

Author

Heiyoun Jung

ChemoCentryx (United States)

Also Known As

Heiyoun Jung

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

ChemoCentryx (United States)University of California, Berkeley Stanford University

About

Heiyoun Jung is an author at ChemoCentryx (United States) specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	446
2	Cell Biology	7	7	446
3	Immunology	5	5	210
4	Pharmacology	1	1	18
5	Cancer Cell Biology	1	1	13

Heiyoun Jung

Publications

446

Citations

H-Index

Page 1

	Year	Citations
Inappropriate p53 activation during development induces features of CHARGE syndrome Jeanine L. Van Nostrand, Colleen A. Brady, Heiyoun Jung, Nature Developmental BiologyGeneticsMedicineCell BiologyInappropriate P53 Activation	2014	136
RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry Heiyoun Jung, Benjamin Hsiung, Kathleen Pestal, The Journal of Experimental Medicine T-regulatory CellImmunologyCell DeathCell CycleNatural Killer Cells	2012	116
Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage Scott T. Younger, Daniela Kenzelmann-Broz, Heiyoun Jung, Nucleic Acids Research Dna DamageGeneticsGenomic MechanismTumor BiologyTranscriptional Regulation	2015	100
Expression of the RAE-1 Family of Stimulatory NK-Cell Ligands Requires Activation of the PI3K Pathway during Viral Infection and Transformation Maria Tokuyama, Clarisse Lorin, Frédéric Delebecque, PLoS Pathogens Viral ReplicationImmunologyViral PathogenesisImmune RegulationViral Infection	2011	52
Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer Heiyoun Jung, A. Bischof, Karen Ebsworth, Journal for ImmunoTherapy of Cancer Breast OncologyImmunologyPharmacotherapyT CellsTumor Biology	2015	18
Abstract A107: Inhibition of CCR2 potentiates the checkpoint inhibitor immunotherapy in pancreatic cancer Heiyoun Jung, Linda Ertl, Christine Janson, Cancer Immunology Research ImmunologyImmunoeditingImmunotherapyCancer BiologyAbstract Pancreatic Cancer	2016	13
Abstract 5655: Inhibition of CCR2 potentiates checkpoint inhibitor immunotherapy in murine model of pancreatic cancer Christine Janson, Heiyoun Jung, Linda Ertl, Cancer Research Abstract Pancreatic CancerCancer ImmunosurveillancePancreatic CancerMedicineTumor Growth	2017	11

Page 1